Vertex Pharmaceuticals income from continuous operations for the twelve months ending September 30, 2024 was $-0.480B, a 113.83% decline year-over-year.
Vertex Pharmaceuticals annual income from continuous operations for 2023 was $3.62B, a 8.96% increase from 2022.
Vertex Pharmaceuticals annual income from continuous operations for 2022 was $3.322B, a 41.84% increase from 2021.
Vertex Pharmaceuticals annual income from continuous operations for 2021 was $2.342B, a 13.63% decline from 2020.
Vertex Pharmaceuticals Income from Continuous Operations 2010-2024 | VRTX